Yu Hongyan, Han Xiaole, Zhang Li, Yin Na, Wang Li, Lv Ke, Wu Yongchang, Bai Dan, Wang Weitao, Huang Ying, Hu Xingping, Weng Zhi, Zhang Chenlu, Yang Gang, Chen Tingmei, Xie Guoming
Key Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.
The Center for Clinical Molecular Medical Detection, Biobank Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf660.
Specific and sensitive DNA hybridization plays a key role in biotechnology, nanotechnology, and medical technology. However, traditional DNA hybridization-based strategies often require careful tuning of the binding affinity of the probe to attain a trade-off between specificity and sensitivity. Herein, we proposed energy barrier-gated dynamic selectivity to overcome this limitation. The mismatch closure-mediated strand displacement reaction (mcSDR) induces structural constraints through helper strand binding at mismatched sites, resulting in the displacement of the mismatch target requires overcoming an additional activation energy barrier, whereas the perfect match target proceeds via a normal pathway. The mcSDR has been thermodynamically and kinetically demonstrated to be able to balance specificity and sensitivity simultaneously. The energy barrier height can be programmably adjusted by design of helper strand and works in synergy with the toehold exchange strategy to achieve multi-parameter optimization. The superior properties of the mcSDR facilitated the identification of 12 mutation types exhibits excellent specificity in 28 clinically relevant single nucleotide variations. By combining polymerase chain reaction, mutations with an abundance of 0.1% were successfully detected in plasmid samples, and a triple mcSDR was successfully constructed. Clinical validation of 95 glioma and 93 colorectal cancer samples showed that IDH1 and KRAS mutations were 100% consistent with Sanger sequencing. The energy barrier-driven identification mechanism and operational simplicity of mcSDR make it promising for wide applications in biomedical research, molecular diagnosis, and precision medicine.
特异性和灵敏的DNA杂交在生物技术、纳米技术和医学技术中发挥着关键作用。然而,传统的基于DNA杂交的策略通常需要仔细调整探针的结合亲和力,以在特异性和灵敏度之间进行权衡。在此,我们提出了能量屏障门控动态选择性来克服这一限制。错配封闭介导的链置换反应(mcSDR)通过辅助链在错配位点的结合诱导结构限制,导致错配靶标的置换需要克服额外的活化能屏障,而完美匹配靶标则通过正常途径进行。mcSDR已在热力学和动力学上被证明能够同时平衡特异性和灵敏度。能量屏障高度可以通过辅助链的设计进行可编程调节,并与引发链交换策略协同工作以实现多参数优化。mcSDR的优异特性有助于在28种临床相关的单核苷酸变异中鉴定出12种突变类型,表现出优异的特异性。通过结合聚合酶链反应,在质粒样品中成功检测到丰度为0.1%的突变,并成功构建了三重mcSDR。对95例胶质瘤和93例结直肠癌样本的临床验证表明,IDH1和KRAS突变与桑格测序100%一致。mcSDR的能量屏障驱动识别机制和操作简便性使其在生物医学研究、分子诊断和精准医学中具有广阔的应用前景。